Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene

被引:36
作者
Hao, Le T. [1 ,2 ]
Burghes, Arthur H. M. [3 ]
Beattie, Christine E. [1 ,2 ]
机构
[1] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
来源
MOLECULAR NEURODEGENERATION | 2011年 / 6卷
关键词
SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; NEUROMUSCULAR-JUNCTIONS; TRANSGENIC ZEBRAFISH; SINGLE NUCLEOTIDE; AXON OUTGROWTH; PROTEIN; MICE; IDENTIFICATION;
D O I
10.1186/1750-1326-6-24
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Animal models of human diseases are essential as they allow analysis of the disease process at the cellular level and can advance therapeutics by serving as a tool for drug screening and target validation. Here we report the development of a complete genetic model of spinal muscular atrophy (SMA) in the vertebrate zebrafish to complement existing zebrafish, mouse, and invertebrate models and show its utility for testing compounds that alter SMN2 splicing. Results: The human motoneuron disease SMA is caused by low levels, as opposed to a complete absence, of the survival motor neuron protein (SMN). To generate a true model of SMA in zebrafish, we have generated a transgenic zebrafish expressing the human SMN2 gene (hSMN2), which produces only a low amount of full-length SMN, and crossed this onto the smn(-/-) background. We show that human SMN2 is spliced in zebrafish as it is in humans and makes low levels of SMN protein. Moreover, we show that an antisense oligonucleotide that enhances correct hSMN2 splicing increases full-length hSMN RNA in this model. When we placed this transgene on the smn mutant background it rescued the neuromuscular presynaptic SV2 defect that occurs in smn mutants and increased their survival. Conclusions: We have generated a transgenic fish carrying the human hSMN2 gene. This gene is spliced in fish as it is in humans and mice suggesting a conserved splicing mechanism in these vertebrates. Moreover, antisense targeting of an intronic splicing silencer site increased the amount of full length SMN generated from this transgene. Having this transgene on the smn mutant fish rescued the presynaptic defect and increased survival. This model of zebrafish SMA has all of the components of human SMA and can thus be used to understand motoneuron dysfunction in SMA, can be used as an vivo test for drugs or antisense approaches that increase full-length SMN, and can be developed for drug screening.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
    Touznik, Aleksander
    Maruyama, Rika
    Hosoki, Kana
    Echigoya, Yusuke
    Yokota, Toshifumi
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Spectrum of Phenotypes in SMA Patients With 4 SMN2 Copies in the French Population
    Gerin, Lorene
    Ropars, Juliette
    Garcia-Uzquiano, Rocio
    De la Banda, Marta Gomez-Garcia
    Saugier-Veber, Pascale
    Desguerre, Isabelle
    Salort-Campana, Emmanuelle
    Espil, Caroline
    Barnerias, Christine
    Laugel, Vincent
    Cances, Claude
    Audic, Frederique
    Cintas, Pascal
    Le Goff, Laure
    Mallaret, Martial
    Nougues, Marie-Christine
    Drunat, Severine
    Tard, Celine
    Grimaldi, Lamiae
    Quijano-Roy, Susana
    NEUROLOGY-GENETICS, 2025, 11 (02)
  • [33] Beyond copy number: A new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients
    Blasco-Perez, Laura
    Paramonov, Ida
    Leno, Jordi
    Bernal, Sara
    Alias, Laura
    Fuentes-Prior, Pablo
    Cusco, Ivon
    Tizzano, Eduardo F.
    HUMAN MUTATION, 2021, 42 (06) : 787 - 795
  • [34] High Expression Level of Tra2-β1 Is Responsible for Increased SMN2 Exon 7 Inclusion in the Testis of SMA Mice
    Chen, Yu-Chia
    Chang, Jan-Gowth
    Jong, Yuh-Jyh
    Liu, Ting-Yuan
    Yuo, Chung-Yee
    PLOS ONE, 2015, 10 (03):
  • [35] Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene
    Pao, Peng Wen
    Wee, Keng Boon
    Yee, Woon Chee
    DwiPramono, Zacharias Aloysius
    MOLECULAR THERAPY, 2014, 22 (04) : 854 - 861
  • [36] Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life
    Steffens, Paula
    Weiss, Deike
    Perez, Anna
    Appel, Manuel
    Weber, Philipp
    Weiss, Claudia
    Stoltenburg, Corinna
    Ehinger, Ute
    von der Hagen, Maja
    Schallner, Jens
    Claussen, Birte
    Lode, Ilka
    Hahn, Andreas
    Schuler, Rahel
    Russ, Lena
    Ziegler, Andreas
    Denecke, Jonas
    Johannsen, Jessika
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 51 : 17 - 23
  • [37] Daily Quantity and Kinematic Characteristics of Leg Movement in a Child With SMA (2 Copies SMN2)
    Mcintyre, Melissa
    Dunn, Lauren
    David, Jed
    Devine, Ceri
    Smith, Beth A.
    PEDIATRIC PHYSICAL THERAPY, 2023, 35 (04) : 486 - 492
  • [38] Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients
    Yamamoto, Tomoto
    Sato, Hideyuki
    San Lai, Poh
    Nurputra, Dian Kesumapramudya
    Harahap, Nur Imma Fatimah
    Morikawa, Satoru
    Nishimura, Noriyuki
    Kurashige, Takashi
    Ohshita, Tomohiko
    Nakajima, Hideki
    Yamada, Hiroyuki
    Nishida, Yoshinobu
    Toda, Soichiro
    Takanashi, Jun-ichi
    Takeuchi, Atsuko
    Tohyama, Yumi
    Kubo, Yuji
    Saito, Kayoko
    Takeshima, Yasuhiro
    Matsuo, Masafumi
    Nishio, Hisahide
    BRAIN & DEVELOPMENT, 2014, 36 (10) : 914 - 920
  • [39] A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
    Prior, Thomas W.
    Krainer, Adrian R.
    Hua, Yimin
    Swoboda, Kathryn J.
    Snyder, Pamela C.
    Bridgeman, Scott J.
    Burghes, Arthur H. M.
    Kissel, John T.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 85 (03) : 408 - 413
  • [40] Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines
    Harahap, Indra Sari Kusuma
    Saito, Toshio
    San, Lai Poh
    Sasaki, Naoko
    Gunadi
    Nurputra, Dian Kesuma Pramudya
    Yusoff, Surini
    Yamamoto, Tomoto
    Morikawa, Satoru
    Nishimura, Noriyuki
    Lee, Myeong Jin
    Takeshima, Yasuhiro
    Matsuo, Masafumi
    Nishio, Hisahide
    BRAIN & DEVELOPMENT, 2012, 34 (03) : 213 - 222